These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 7756099)

  • 21. Captopril enhances renal responsiveness to ANF in dogs with compensated high-output heart failure.
    Villarreal D; Freeman RH; Johnson RA
    Am J Physiol; 1992 Mar; 262(3 Pt 2):R509-16. PubMed ID: 1313653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system.
    Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Sørensen SS; Pedersen EB
    Am J Physiol; 1991 Jun; 260(6 Pt 2):F883-9. PubMed ID: 1647690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there a role for renin profiling in selecting chronic heart failure patients for ACE inhibitor treatment?
    Lim PO; MacFadyen RJ; Struthers AD
    Heart; 2000 Mar; 83(3):257-61. PubMed ID: 10677399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of intravenous frusemide on urine dopamine in normal volunteers: studies with indomethacin and carbidopa.
    Jeffrey RF; Macdonald TM; Rutter M; Freestone S; Brown J; Samson RR; Lee MR
    Clin Sci (Lond); 1987 Aug; 73(2):151-7. PubMed ID: 3652622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
    Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
    Mentz RJ; Stevens SR; DeVore AD; Lala A; Vader JM; AbouEzzeddine OF; Khazanie P; Redfield MM; Stevenson LW; O'Connor CM; Goldsmith SR; Bart BA; Anstrom KJ; Hernandez AF; Braunwald E; Felker GM
    JACC Heart Fail; 2015 Feb; 3(2):97-107. PubMed ID: 25543972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute effects of captopril on the renal actions of furosemide in patients with chronic heart failure.
    McLay JS; McMurray JJ; Bridges AB; Fraser CG; Struthers AD
    Am Heart J; 1993 Oct; 126(4):879-86. PubMed ID: 8213445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Na+, K+, and BP homeostasis in man during furosemide: effects of prazosin and captopril.
    Wilcox CS; Guzman NJ; Mitch WE; Kelly RA; Maroni BJ; Souney PF; Rayment CM; Braun L; Colucci R; Loon NR
    Kidney Int; 1987 Jan; 31(1):135-41. PubMed ID: 3550214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention.
    Hensen J; Abraham WT; Dürr JA; Schrier RW
    Am J Nephrol; 1991; 11(6):441-6. PubMed ID: 1840232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Indomethacin and furosemide in patients with cardiac insufficiency. Kidney function, the renin-angiotensin system and renal prostaglandins].
    Kahles H; Riegger AJ
    Dtsch Med Wochenschr; 1987 Nov; 112(45):1737-40. PubMed ID: 3315542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
    Dzau VJ
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natriuretic efficiency of frusemide as a consequence of drug input rate.
    Wakelkamp M; Alván G; Paintaud G
    Br J Clin Pharmacol; 1997 May; 43(5):481-91. PubMed ID: 9159563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure.
    Cleland JG; Gillen G; Dargie HJ
    Eur Heart J; 1988 Feb; 9(2):132-41. PubMed ID: 2832173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactive effects of indomethacin, angiotensin II and frusemide on renal haemodynamics and natriuresis in man.
    Motwani JG; Struthers AD
    Br J Clin Pharmacol; 1994 Apr; 37(4):355-61. PubMed ID: 8018457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of angiotensin-converting enzyme inhibition on renal sodium handling after furosemide injection.
    Nowack R; Fliser D; Richter J; Horne C; Mutschler E; Ritz E
    Clin Investig; 1993 Aug; 71(8):622-7. PubMed ID: 8219659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
    Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease.
    Dzau VJ; Swartz SL
    Am J Cardiol; 1987 Nov; 60(13):1101-5. PubMed ID: 3314460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldosterone breakthrough with benazepril in furosemide-activated renin-angiotensin-aldosterone system in normal dogs.
    Lantis AC; Ames MK; Atkins CE; DeFrancesco TC; Keene BW; Werre SR
    J Vet Pharmacol Ther; 2015 Feb; 38(1):65-73. PubMed ID: 25224804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Renal effects of captopril in chronic heart failure].
    Zolotov NA; Kiriaev AA; Merzon AK; Mukharliamov NM
    Ter Arkh; 1988; 60(8):46-51. PubMed ID: 3067412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of captopril to estimate renin-angiotensin-aldosterone activity in the pathophysiology of chronic heart failure.
    Cody RJ; Laragh JH
    Am Heart J; 1982 Nov; 104(5 Pt 2):1184-9. PubMed ID: 6291364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.